Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i)
The p38 mitogen-activated protein kinase (p38-MAPK) is a crucial signaling pathway closely involved in several physiological and cellular functions, including cell cycle, apoptosis, gene expression, and responses to stress stimuli. It also plays a central role in inflammation and immunity. Owing to...
Saved in:
Main Authors: | Payal Ganguly (Author), Tom Macleod (Author), Chi Wong (Author), Mark Harland (Author), Dennis McGonagle (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site
by: Utid Suriya, et al.
Published: (2022) -
Mitogen Activated Protein Kinases
by: Jose Lozano
Published: (2017) -
The case for inhibiting p38 mitogen-activated protein kinase in heart failure
by: Pelin eArabacilar, et al.
Published: (2015) -
Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
by: Haichuan Yu, et al.
Published: (2022) -
p38 Mitogen-Activated Protein Kinase Regulates Vasoconstriction in Spontaneously Hypertensive Rats
by: Seongchun Kwon, et al.
Published: (2004)